Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling. (18th December 2022)
- Record Type:
- Journal Article
- Title:
- Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling. (18th December 2022)
- Main Title:
- Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling
- Authors:
- Genovese, Michele
Buccirossi, Martina
Guidone, Daniela
De Cegli, Rossella
Sarnataro, Sergio
di Bernardo, Diego
Galietta, Luis J. V. - Abstract:
- Abstract : Background and Purpose: Pharmacological inhibitors of TMEM16A (ANO1), a Ca 2+ ‐activated Cl − channel, are important tools of research and possible therapeutic agents acting on smooth muscle, airway epithelia and cancer cells. We tested a panel of TMEM16A inhibitors, including CaCCinh ‐A01, niclosamide, MONNA, Ani9 and niflumic acid, to evaluate their possible effect on intracellular Ca 2+ . Experimental Approach: We recorded cytosolic Ca 2+ increase elicited with UTP, ionomycin or IP3 uncaging. Key Results: Unexpectedly, we found that all compounds, except for Ani9, markedly decreased intracellular Ca 2+ elevation induced by stimuli acting on intracellular Ca 2+ stores. These effects were similarly observed in cells with and without TMEM16A expression. We investigated in more detail the mechanism of action of niclosamide and CaCCinh ‐A01. Acute addition of niclosamide directly increased intracellular Ca 2+, an activity consistent with inhibition of the SERCA pump. In contrast to niclosamide, CaCCinh ‐A01 did not elevate intracellular Ca 2+, thus implying a different mechanism of action, possibly a block of inositol triphosphate receptors. Conclusions and Implications: Most TMEM16A inhibitors are endowed with indirect effects mediated by alteration of intracellular Ca 2+ handling, which may in part preclude their use as TMEM16A research tools. Abstract : ▪▪
- Is Part Of:
- British journal of pharmacology. Volume 180:Number 6(2023)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 180:Number 6(2023)
- Issue Display:
- Volume 180, Issue 6 (2023)
- Year:
- 2023
- Volume:
- 180
- Issue:
- 6
- Issue Sort Value:
- 2023-0180-0006-0000
- Page Start:
- 775
- Page End:
- 785
- Publication Date:
- 2022-12-18
- Subjects:
- chloride channel -- inositol triphosphate receptor -- purinergic receptor -- calcium signaling
Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.15995 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25972.xml